Physician profile

Christopher Eugene Clark

Surgery · Lucedale, MS

NPI 1962704999

$7,146.40

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$58.51

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $4,913.27 2019
Medtronic Vascular, INC. $1,057.48 2020
Boston Scientific Corporation $917.62 2019
Olympus America INC. $112.44 2019-2020
Ossur Americas, INC. $44.89 2024
Bard Access Systems, INC. $38.60 2019
Davol INC. $33.62 2020
Covidien LP $14.86 2019
Integra Lifesciences Corporation $13.62 2024 Inspira Air, Acclarent Aera, Trudi Probe

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher Eugene Clark

$7,146.40

in general payments reported 2019-2025

Years
2019-2024
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/225499/christopher-eugene-clark

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.